Shanghai Shyndec Pharmaceutical Co., Ltd. (SHA:600420)
8.70
-0.20 (-2.25%)
Jun 9, 2026, 3:00 PM CST
SHA:600420 Market Cap
SHA:600420 has a market cap or net worth of 11.67 billion as of June 9, 2026. Its market cap has decreased by -15.78% in one year.
Market Cap
11.67B
Enterprise Value
10.10B
Revenue
8.82B
Ranking
n/a
PE Ratio
16.24
Stock Price
8.70
Market Cap Chart
Since August 23, 2004, SHA:600420's market cap has increased from 833.55M to 11.67B, an increase of 1,299.81%. That is a compound annual growth rate of 12.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 11.94B | -11.88% |
| Dec 31, 2025 | 13.55B | -15.41% |
| Dec 31, 2024 | 16.01B | 21.96% |
| Dec 29, 2023 | 13.13B | 40.50% |
| Dec 30, 2022 | 9.35B | -12.25% |
| Dec 31, 2021 | 10.65B | 9.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanjing King-Friend Biochemical Pharmaceutical | 12.98B |
| Shenzhen Hepalink Pharmaceutical Group | 12.79B |
| Guobang Pharma | 12.44B |
| Henan Lingrui Pharmaceutical | 12.25B |
| Beijing Aosaikang Pharmaceutical | 11.99B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 11.98B |
| Zhejiang Medicine | 11.54B |
| Hubei Hongyuan Pharmaceutical Technology | 11.43B |